Phase 4
N=74
Tenaculum Pain Control Study
Cervical Pain · Pelvic Pain
Bottom Line
View on ClinicalTrials.gov: NCT01421641 ↗Enrolled (actual)
74
Serious AEs
0.0%
Results posted
Apr 2014
Primary outcome: Primary: Tenaculum Pain — 12.3; 36.6 mm
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Intracervical Lidocaine Injection (Drug); Topical Lidocaine Gel (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Oregon Health and Science University
- Primary completion
- May 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Tenaculum Pain |
12.3; 36.6 | — |
| SECONDARY Intervention Pain |
20.4; 5.9 | — |
| SECONDARY Tenaculum Placement Satisfaction |
79.9; 74.6 | — |
Summary
The purpose of this clinical trial is to evaluate the effect of an intracervical lidocaine injection versus topical lidocaine gel on the pain experienced by patients undergoing tenaculum application to the cervix during office gynecologic procedures. This study will also evaluate how satisfied women are with the method of pain control used.
The researchers hypothesize that:
1. There is less pain perceived by patients undergoing placement of a tenaculum on the cervix when a lidocaine injection is used compared to a topical lidocaine gel.
2. Patients are more satisfied with pain control during the overall experience of undergoing tenaculum placement on the cervix when a lidocaine injection is used compared to a topical lidocaine gel.
Eligibility Criteria
Inclusion Criteria
- Generally healthy women
- Age 18 and over
- Indication for endometrial biopsy or IUD placement
Exclusion Criteria
- Allergy to lidocaine or other local anesthetic
- Pregnancy, known or suspected
- Patients who are premedicated with misoprostol
- Patients with a chronic pain condition for which the patient takes daily pain medication
Data sourced from ClinicalTrials.gov (NCT01421641). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.